Invesco Ltd.

Position in NAUT — Nautilus Biotechnology, Inc.

CIK 914208 Atlanta, GA

Position in NAUT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$65,823

+$51,100 QoQ

Shares Held

35,200

+105.8% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#52

of 93 holders

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 0% Shared 96% None 4%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. NAUT ranks #287 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$65,823	35,200	+105.8%	Shares	Defined	2026-08-14
2025-03-31	$14,723	17,101	-4.4%	Shares	Defined	2025-05-12
2024-12-31	$30,038	17,881	-13.3%	Shares	Defined	2025-02-13
2024-09-30	$58,765	20,620	-2.9%	Shares	Defined	2024-11-12
2024-06-30	$49,712	21,245	-7.9%	Shares	Defined	2024-08-13
2024-03-31	$67,801	23,062	+1.5%	Shares	Defined	2024-05-14
2023-12-31	$67,908	22,712	+28.3%	Shares	Defined	2024-02-13
2023-09-30	$55,937	17,702	+0.4%	Shares	Defined	2023-11-13
2023-06-30	$68,247	17,635	-1.6%	Shares	Defined	2023-08-11
2023-03-31	$49,645	17,923	-5.9%	Shares	Defined	2023-05-12
2022-12-31	$34,282	19,046	-1.0%	Shares	Defined	2023-02-13
2022-09-30	$40,786	19,239	-0.9%	Shares	Defined	2022-11-14
2022-06-30	$52,206	19,408	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.